RNA-Targeted Drug Discovery Summit 2018

Start Date : December 3, 2018
End Date : December 5, 2018
Time : 8:00 am to6:00 pm

Phone : +16174554188
Email : info@hansonwade.com

Location :
DoubleTree Suites by Hilton Hotel Boston - Cambridge, 400 Soldiers Field Road, 02134, Boston, United States

Website

Description

With our increased understanding of RNA structure and function, and RNA-small molecule binding behaviour a plethora of previously undruggable targets are opening up.

 

As such, I wanted to introduce to you to the 1st RNA-Targeted Drug Discovery Summit 2018 (Boston, MA – December 3-6, 2018) – a niche scientific and networking forum, carefully curated from those at large pharma, biotech and academia who are pioneering the next generation of small molecule drug discovery.

 

The 1st RNA-Targeted Drug Discovery Summit will bring together a unique community of experts, devoted to optimizing the process of discovering and designing small molecules that bind specifically to quality RNA targets and translating these into clinically safe and effective therapies. Sounds interesting? Get your free event brochure copy to find out more: http://bit.ly/2C7derg

 

Meet with experts and come away with: 

-Deep understanding of how to translate the structure, dynamics and function of RNA into lead small molecules with insights from Matthew Disney, Founder, Expansion Therapeutics & Professor, Scripps Research Institute. Explore experimental approaches that support target engagement in cells to support compound mode of action.

-Explore the discovery, structure and cellular activity of small molecule inhibitors of cellular and viral RNAs through the insights delivered by Gabriele Varani, Professor of Chemistry, University of Washington.

-Understand principles for targeting RNA with small molecules with perspectives from Kevin Weeks, Professor, UNC to help structure your research into targeting RNA

 

I hope you can join this rapidly emerging community in Boston this December in order to overcome the target identification and validation, selective binding and chemistry challenges facing those trying to translate novel small molecules that successfully target therapeutically relevant RNA, and accelerate them into the clinic.

 

Prices:

Full Price – Industry – Conference + Workshop (check website for Early Bird Discounts)USD 3398.0

Full Price – Academia – Conference + Workshop (check website for Early Bird Discounts)USD 2298.0

Brochure https://go.evvnt.com/271645-0?pid=3506

Speakers: Matthew Disney, Founder, Expansion Therapeutics & Professor, Scripps Research Institute, Kevin Weeks, Professor, UNC, Matt Woll, Senior Director of Chemistry, PTC Therapeutics, Anne Boriack-Sjodin, VP of Molecular Discovery, Accent Therapeutics, Razvan Nutiu, Investigator III, Novartis , Benjamin Miller, Principal Investigator, URMC, Jennifer Petter, Founder & CSO, Arrakis Therapeutics, Gabriele Varani, Professor of Chemistry, University of Washington

Registration Info

Register Now

 

Organized by

Organized by LoveEvvnt1

Hanson Wade Ltd


Event Categories: Internal Medicine.

Your Review

You must be logged in to post a comment.